FDA In 'Very Early Stages' of Looking at Centralized Document Review
The FDA is in the beginning stages of looking at a centralized review model for import entry, said a FDA spokeswoman. "FDA is currently exploring the idea of using a 'centralized' review model for import entry review," she said. "This…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
exploration is in the very early stages and will be looking at whether the model is feasible, whether any efficiencies could be expected from such a model, if there would be any benefits to FDA and/or the regulated industry from such a model." An FDA official recently discussed the issue at the National Customs Brokers and Forwarders Association of America conference. (See ITT's Online Archives 12091423 for summary of the FDA official's remarks.)